MwanzoADVM • NASDAQ
add
Adverum Biotechnologies Inc
Bei iliyotangulia
$ 4.52
Bei za siku
$ 4.23 - $ 4.51
Bei za mwaka
$ 4.23 - $ 29.60
Thamani ya kampuni katika soko
88.83M USD
Wastani wa hisa zilizouzwa
elfu 218.97
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.00M | — |
Matumizi ya uendeshaji wa biashara | 9.78M | -29.06% |
Mapato halisi | -27.13M | 17.49% |
Kiwango cha faida halisi | elfu -2.71 | — |
Mapato kwa kila hisa | -1.30 | 60.61% |
EBITDA | -28.33M | 14.20% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 153.24M | 30.88% |
Jumla ya mali | 234.38M | 19.11% |
Jumla ya dhima | 90.26M | -4.04% |
Jumla ya hisa | 144.12M | — |
hisa zilizosalia | 20.80M | — |
Uwiano wa bei na thamani | 0.65 | — |
Faida inayotokana na mali | -29.93% | — |
Faida inayotokana mtaji | -31.81% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -27.13M | 17.49% |
Pesa kutokana na shughuli | -21.12M | 11.66% |
Pesa kutokana na uwekezaji | -13.35M | -173.34% |
Pesa kutokana na ufadhili | 0.00 | 100.00% |
Mabadiliko halisi ya pesa taslimu | -34.47M | -492.17% |
Mtiririko huru wa pesa | -11.77M | 36.71% |
Kuhusu
Adverum Biotechnologies, Inc., formerly known as Avalanche Biotechnologies, is a publicly traded clinical stage gene therapy company located in Redwood City, California. The company is targeting unmet medical needs for serious ocular and rare diseases, including wet age-related macular degeneration. Wikipedia
Ilianzishwa
1 Jan 2006
Makao Makuu
Tovuti
Wafanyakazi
121
